DeepIntent vs Doximity

DeepIntent Launches Cora, the First Fully Agentic Marketing Platform for Healthcare

DeepIntent announced the launch of Cora, described as the first fully agentic marketing platform for healthcare, marking a significant product introduction.

DeepIntent launches agentic ad platform Cora for pharma marketing

DeepIntent, a healthcare-focused adtech firm, has launched Cora, an AI-powered agentic advertising platform designed for pharmaceutical marketers. The platform uses multiple AI agents to handle campaign planning, audience strategy, and media execution, including linear TV via a VideoAmp integration. Cora aims to speed up marketing workflows, with beta tests showing a 50% reduction in planning cycles and over 95% of clients reporting faster processes. This launch follows DeepIntent's majority stake sale to Vitruvian Partners, which provided $637 million to develop AI tools. The company targets the growing complexity of pharma marketing, especially for niche drugs targeting small patient populations. Cora is also powered by Helix, a data application providing aggregated healthcare data, including payer signals and drug coverage insights.

• DeepIntent launched Cora, an agentic ad platform for pharma marketing.
• Cora uses AI agents for campaign planning, audience targeting, and execution.
• Cora integrates with VideoAmp for linear TV campaign execution.

DeepIntent Expands Inventory Marketplace with Vistar Media Partnership, Bringing Premium Digital Out-of-Home Inventory to Healthcare Marketers

DeepIntent Expands Inventory Marketplace with Vistar Media Partnership, Bringing Premium Digital Out-of-Home Inventory to Healthcare Marketers

Novant Health Partners with Doximity to Bring Evidence-Based Clinical AI Into Epic

Doximity announces new partnerships with Novant Health and Penn Highlands Healthcare to deploy its Clinical AI Suite, and releases the 2026 Physician Compensation Report highlighting AI fluency as a career advantage.

Penn Highlands Healthcare Partners with Doximity to Launch System-Wide Clinical AI Suite

Doximity announces a partnership with Penn Highlands Healthcare to deploy its Clinical AI Suite system-wide.

Doximity Shares More Than Double After AI Remarks

Shares of Doximity more than doubled in premarket trading after CEO Jeffrey Tangney said the company’s new AI search product generates over ten times the revenue per search versus its cost. Doximity reported fiscal Q1 2027 revenue of $156.6 million and adjusted EBITDA of $74.8 million, both beating estimates, and raised its full-year revenue guidance by $6 million to a range of $671 million–$681 million. Analysts note that the updated guidance likely does not fully incorporate AI search revenue. Elevated short interest (about 17% of float) contributed to a rapid squeeze as positions were unwound. The stock surge followed comments on AI unit economics made on the company’s earnings call.

• Doximity reported fiscal Q1 2027 revenues of $156.6 million and adjusted EBITDA of $74.8 million, both above consensus estimates.
• Doximity raised its full-year 2027 revenue guidance by $6 million to a range of $671 million to $681 million.
• CEO Jeffrey Tangney said the company’s AI search product earns more than 10 times the revenue per search compared with its cost to run.